CIN-107
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CIN-107, covering 2023-06-28 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CIN-107 in Adults With Primary Aldosteronism [Phase 2]